Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M97.5Revenue $M0.3Net Margin (%)0Z-Score-15.3
Enterprise Value $M85.2EPS $-0.5Operating Margin %0F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book9.510-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-44.7Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-108.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-190.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M69.1ROI % (ttm)-108.6Gross Margin Increase y-yN

Gurus Latest Trades with ETRM

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ETRMBill Gates 2009-06-30 Sold Out $7.5 - $24.36
($14.28)
$ 1.41-90%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ETRM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ETRM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FRIEDMAN CATHYDirector 2014-06-19Buy11,800$1.7-20view
EVNIN LUKEDirector 2014-01-08Sell556,585$2.5-45.6view
EVNIN LUKEDirector 2014-01-08Sell556,585$2.5-45.6view
Jansz Anthony P.Director 2013-02-27Buy150,000$0.9543.16view
WHITEBOX ADVISORS LLC 2012-06-27Sell47,499$3.22-57.76view
WHITEBOX ADVISORS LLC 2012-06-22Sell19,065$3.14-56.69view
WHITEBOX ADVISORS LLC 2012-05-15Sell38,412$2.85-52.28view
WHITEBOX ADVISORS LLC 2012-05-11Sell10,970$2.76-50.72view
WHITEBOX ADVISORS LLC 2012-04-27Sell25,000$2.8-51.43view
WHITEBOX ADVISORS LLC 2012-04-17Sell25,439$2.35-42.13view

Press Releases about ETRM :

    Quarterly/Annual Reports about ETRM:

    News about ETRM:

    Articles On GuruFocus.com
    EnteroMedics Inc. Reports Operating Results (10-K) Mar 07 2011 
    EnteroMedics Inc. Reports Operating Results (10-Q) Nov 08 2010 
    EnteroMedics Inc. Reports Operating Results (10-Q) Aug 06 2010 
    EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2010 
    EnteroMedics Inc. Reports Operating Results (10-Q) Nov 16 2009 
    EnteroMedics Inc. Reports Operating Results (10-Q) Aug 07 2009 
    EnteroMedics Inc. Reports Operating Results (10-Q) May 07 2009 
    EnteroMedics Reports 2008 Year-End Financial Results Jan 29 2009 


    More From Other Websites
    Nasdaq stocks posting largest volume increases Dec 16 2014
    ENTEROMEDICS INC Financials Nov 21 2014
    Can The Uptrend Continue for EnteroMedics (ETRM)? Nov 20 2014
    10-Q for EnteroMedics, Inc. Nov 14 2014
    EnteroMedics to Participate at the 2014 Canaccord Genuity Medical Technology and Diagnostics Forum Nov 13 2014
    EnteroMedics to Participate at the 2014 Canaccord Genuity Medical Technology and Diagnostics Forum Nov 13 2014
    ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 12 2014
    EnteroMedics Reports Third Quarter 2014 Financial Results Nov 12 2014
    Q3 2014 EnteroMedics Inc Earnings Release - Before Market Open Nov 12 2014
    EnteroMedics Reports Third Quarter 2014 Financial Results Nov 12 2014
    ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Oct 30 2014
    EnteroMedics Names Brad Hancock Chief Commercial Officer Oct 30 2014
    EnteroMedics Names Brad Hancock Chief Commercial Officer Oct 30 2014
    ENTEROMEDICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 01 2014
    Pressure Biosciences, Inc. (PBIO) Benefits From Surge In Life Sciences and Medical Technology... Sep 29 2014
    Treatment of Type 2 Diabetes Mellitus added to EnteroMedics CE Mark for Obesity Sep 29 2014
    Journal of the American Medical Association Publishes EnteroMedics' ReCharge Pivotal Trial Results Sep 03 2014
    EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro® RC... Aug 28 2014
    ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
    ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK